allergic conjunctivitis
Conditions
Interventions
Diphenhydramine ointment of 1/4 Finger tip units will be applied to each eyelid twice a day for 2 weeks.
Sponsors
National Hospital Organization Disaster Medical Center Department of pulmonology
Faculty of Pharmaceutical Sciences, Josai University
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: # Patients with allergic conjunctivitis. # Persistent symptoms despite the conventional treatment such as anti-histamine topically or orally given. # No change of drugs 4 weeks prior to the enrollment.
Exclusion criteria
Exclusion criteria: # Those with underlying dermal disease of eyelids such as atopic dermatitis. # Those with newly introdeced anti-allergic, anti-histamine, steroids. # Patients with pregnancy and lactation. # Those whom the attending clinicians regard to be unsuitable to the enrollment to the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Subjective effectiveness by the patients, 2 weeks after the introduction of the therapy. | — |
Secondary
| Measure | Time frame |
|---|---|
| adverse effects (vision test, intraocular pressure) objective effectiveness judged by clinicians. QOL. | — |
Countries
Japan
Contacts
Public ContactMitsuhiro Kamimura
National Hospital Organization Disaster Medical Center Department of pulmonology
Outcome results
None listed